Neuroendocrine peptides in the prostate

Urological Research

Volumn 23, Issue 2, 1995, Pages 81-87

  Gkonos, P J ^a,b   Krongrad, A ^a,b   Roos, B A ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

Neuroendocrine cells; Neuropeptides; Prostate; Prostate carcinoma

Indexed keywords

NEUROPEPTIDE;

ARTICLE; CARCINOGENESIS; HUMAN; NEUROSECRETORY CELL; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER;

ANDROGENS; ANIMAL; HUMAN; MALE; NEUROPEPTIDES; NEUROSECRETORY SYSTEMS; PEPTIDES; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 0029039010     PISSN: 03005623     EISSN: 14340879     Source Type: Journal    
DOI: 10.1007/BF00307937     Document Type: Editorial

References (69)

1. Partial characterization of a thyroid-stimulating hormone-like peptide in neuroendocrine cells of the human prostate gland
2. Peptide-hormone- and serotonin-immunoreactive cells in normal and hyperplastic prostate glands
3. The course of neuroendocrine differentiation in prostatic carcinomas
4. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma
5. Ballantyne G, Goldenring JR, Fleming FX, Rush S, Flint JS, Fielding LP, Binder HJ, Modlin IM (1993) Inhibition of VIP-stimulated ion transport by a novel Y-receptor phenotype in rabbit distal colon. Am J Physiol 264:G848
6. Bombesin stimulates growth of human prostatic cancer cells in vitro
7. Relation of endocrine-paracrine cell proliferation in normal, hyperplastic, and neoplastic human prostate
8. Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic, and neoplastic human prostate
9. Neurologic control of prostatic secretion in the dog
10. Parathyroid hormone-related peptide can function as an autocrine growth factor in human renal cell carcinoma
11. Cyclic AMP response to vasoactive intestinal peptide and [beta]-adrenergic or cholinergic agonists in isolated epithelial cells of rat ventral prostate
12. VIP binding to epithelial cell membranes of rat ventral prostate: effect of guanine nucleotides
13. The innervation of the human prostate gland—the changes associated with benign enlargement
14. Relationship of neuroendocrine cells of prostate and serotonin to benign prostatic hyperplasia
15. The TRH-related peptide pyroglutamylglutamylprolineamide is present in human semen
16. A novel peptide, pyroglutamylglutamylprolineamide, in the rabbit prostate complex, structurally related to thyrotrophin-releasing hormone
17. Prostatic carcinoma: histological and immunohistological factors affecting prognosis
18. Neuro-endocrine cells—a new prognostic parameter in prostate cancer
19. The neuroendocrine cell population of the human prostate gland
20. The human prostate gland: a histochemical and immunohistochemical study of neuropeptides, serotonin, dopamine [beta]-hydroxylase and acetylcholinesterase in autonomic nerves and ganglia
21. The neuroendocrine prostate: characterization and quantitation of calcitonin in the human gland
22. Calcitonin-like immunoreactive and bombesin-like immunoreactive endocrine-paracrine cells of the human prostate
23. Neuroendocrine differentiation in carcinoma of the prostate
24. Neuroendocrine differentiation in prostatic carcinoma
25. Calcitonin, katacalcin, and calcitonin gene-related peptide in the human prostate
26. Radioautographic localization of [beta]-adrenergic receptors in the rat ventral prostate
27. Calcitonin-secreting carcinomas of the prostate
28. Beta-endorphin, met-enkephalin and calcitonin in human semen: evidence for a possible role in human sperm motility
29. The expression of prostatic TRH-like peptides differs between species and between malignant and nonmalignant tissues
30. Identification of the human seminal TRH-like peptide pGlu-Phe-Pro-NH2 in normal human prostate
31. Isolation of a human seminal plasma peptide with bombesin-like activity
32. Neuropeptide Y inhibits [beta]-adrenergic agonist- and vasoactive intestinal peptide-induced cyclic AMP accumulation in rat pinealocytes through pertussis toxin-sensitive G protein
33. Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide, and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells
34. Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor
35. Immunohistochemical localization of parathyroid hormone-related protein in human prostate cancer
36. Parathyroid hormone-related protein is expressed by prostatic neuroendocrine cells
37. Isolation and identification of two neutral thyrotropin releasing hormone-like peptides, pyroglutamylphenylalanineprolineamide and pyroglutamylglutamineprolineamide, from human seminal fluid
38. Peptidergic innervation within the prostate gland and seminal vesicle
39. The emerging role of alpha antagonists in the therapy of benign prostatic hyperplasia
40. Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP
41. Expression of luteinizing hormone-releasing hormone mRNA in the human prostatic cancer cell line LNCaP
42. Hypercalcemia in prostatic carcinoma. Report of eight cases
43. The TRH-like peptide pGlu-Glu-Pro-NH2 is present in human prostate and may affect sperm motility
44. The androgen receptor status of neuroendocrine cells in human benign and malignant prostate tissue
45. Phosphorylation of steroid hormone receptors
46. High concentrations of pGlu-His-Pro-NH2 (thyrotropin-releasing hormone) occur in rat prostate
47. Human semen contains thyrotropin releasing hormone (TRH), a TRH-homologous peptide, and TRH-binding substances
48. Dopamine activation of an orphan member of the steroid receptor superfamily
49. Zur Frage der Endokrinie der menschlichen Vorsteherdrüse
50. The effects of gonadotropin releasing hormone analogues in prostate cancer are mediated through specific tumour receptors
51. Bombesin stimulation of DNA synthesis and cell division in cultures of Swiss 3T3 cells
52. Immunoreactive somatostatin in male reproductive system in humans
53. Present status of agonistic and antagonistic analogs of LH-RH in the treatment of advanced prostate cancer
54. Presence of calcitonin-like immunoreactivity (iCT) in human prostate gland: evidence for iCT secretion by cultured prostate cells
55. Anatomy of the lower urinary tract
56. Small cell carcinoma of the prostate, part 1
57. Co-release of neuropeptide Y (NPY) and noradrenaline from the sympathetic nerve terminals supplying the rat vas deferens; influence of calcium and the stimulation intensity
58. Neuroendocrine differentiation in prostatic carcinomas
59. Innervation of the ventral prostate of the rat
60. Determination of prostatic secretion in rats: effect of neurotransmitters and testosterone
61. Requirement of innervation for maintenance of structural and functional integrity in the rat prostate
62. Effect of bombesin, bradykinin, substance P and CGRP in prostate, bladder body and neck
63. Gastrin-releasing peptide is a selective mitogen for small cell lung carcinoma in vitro
64. Bombesin and the C-terminal tetradecapeptide of gastrin-releasing peptide are growth factors for normal human bronchial epithelial cells
65. Multiple signaling pathways activate the chicken progesterone receptor
66. Neuropeptide Y inhibits forskolin-stimulated adenylate cyclase in bovine adrenal chromaffin cells via a pertussis toxin-sensitive process